(2Z)-2-{[3-(1-benzyl-1H-indol-3-yl)-1-(3-chlorophenyl)-1H-pyrazol-5-yl]imino}-1,3-thiazolidin-4-one

ID: ALA5278629

Max Phase: Preclinical

Molecular Formula: C27H20ClN5OS

Molecular Weight: 498.01

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C1CS/C(=N\c2cc(-c3cn(Cc4ccccc4)c4ccccc34)nn2-c2cccc(Cl)c2)N1

Standard InChI:  InChI=1S/C27H20ClN5OS/c28-19-9-6-10-20(13-19)33-25(29-27-30-26(34)17-35-27)14-23(31-33)22-16-32(15-18-7-2-1-3-8-18)24-12-5-4-11-21(22)24/h1-14,16H,15,17H2,(H,29,30,34)

Standard InChI Key:  RYFAGLFXRLWQSM-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 35 40  0  0  0  0  0  0  0  0999 V2000
   -0.1768    1.2716    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.6481    1.2716    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.8983    0.4676    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2447   -0.0030    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4226    0.4888    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6950    0.2541    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9085   -0.5425    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7051   -0.7560    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.7387   -1.5970    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9858   -1.8825    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4685   -1.2348    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.4529   -2.0095    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2194    0.2754    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4328   -0.5212    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2739   -0.5547    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5593    0.1981    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9116    0.7153    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3286    0.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4529    1.3197    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8096    1.8358    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0364    1.5384    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0606    1.9859    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6484    2.7004    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0602    3.4122    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8852    3.4122    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2970    2.7022    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8889    1.9859    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6863   -1.2690    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2739   -1.9833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4490   -1.9835    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0386   -2.6961    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4511   -3.4106    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2718   -3.4122    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6881   -2.7007    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1217    2.7022    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  1  5  2  0
  5  4  1  0
  3  6  1  0
  6  7  2  0
  8  7  1  0
  8  9  1  0
  9 10  1  0
 11 10  1  0
  7 11  1  0
  9 12  2  0
  5 13  1  0
 14 13  2  0
 14 15  1  0
 15 16  1  0
 17 16  2  0
 13 17  1  0
 16 18  1  0
 19 18  2  0
 20 19  1  0
 21 20  2  0
 17 21  1  0
  2 22  1  0
 23 22  2  0
 24 23  1  0
 25 24  2  0
 26 25  1  0
 27 26  2  0
 22 27  1  0
 15 28  1  0
 28 29  1  0
 30 29  2  0
 31 30  1  0
 32 31  2  0
 33 32  1  0
 34 33  2  0
 29 34  1  0
 26 35  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5278629

    ---

Associated Targets(Human)

BEAS-2B (690 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-MEL-28 (48833 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

B16-F10 (4610 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 498.01Molecular Weight (Monoisotopic): 497.1077AlogP: 6.05#Rotatable Bonds: 5
Polar Surface Area: 64.21Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 7.57CX Basic pKa: 0.72CX LogP: 6.64CX LogD: 6.42
Aromatic Rings: 5Heavy Atoms: 35QED Weighted: 0.32Np Likeness Score: -1.53

References

1. Soni JP, Chilvery S, Sharma A, Reddy GN, Godugu C, Shankaraiah N..  (2023)  Design, synthesis and in vitro cytotoxicity evaluation of indolo-pyrazoles grafted with thiazolidinone as tubulin polymerization inhibitors.,  14  (3): [PMID:36970141] [10.1039/d2md00442a]

Source